Pharvaris NV (PHVS)
38.66
+0.92
(+2.44%)
USD |
NASDAQ |
Sep 10, 11:45
Pharvaris Price : 38.66 for Sept. 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 09, 2026 | 38.26 | 39.18 | 37.05 | 37.74 | 1.427M |
| Sep 08, 2026 | 40.96 | 43.25 | 37.60 | 37.84 | 6.328M |
| Sep 04, 2026 | 35.36 | 36.39 | 35.21 | 35.25 | 483983.0 |
| Sep 03, 2026 | 35.39 | 35.88 | 34.58 | 35.66 | 357063.0 |
| Sep 02, 2026 | 35.05 | 35.97 | 34.04 | 35.17 | 320877.0 |
| Sep 01, 2026 | 34.45 | 35.07 | 33.80 | 34.93 | 394435.0 |
| Aug 31, 2026 | 35.31 | 35.73 | 34.13 | 34.61 | 557515.0 |
| Aug 28, 2026 | 37.00 | 37.40 | 35.26 | 35.32 | 479030.0 |
| Aug 27, 2026 | 37.00 | 37.49 | 36.30 | 37.00 | 765049.0 |
| Aug 26, 2026 | 37.31 | 37.40 | 36.24 | 37.00 | 448942.0 |
| Aug 25, 2026 | 37.32 | 38.00 | 36.69 | 37.23 | 861175.0 |
| Aug 24, 2026 | 36.27 | 38.13 | 35.70 | 37.31 | 691824.0 |
| Aug 21, 2026 | 36.61 | 36.93 | 36.12 | 36.27 | 515459.0 |
| Aug 20, 2026 | 36.13 | 36.82 | 35.45 | 36.39 | 627798.0 |
| Aug 19, 2026 | 36.80 | 36.88 | 35.54 | 36.27 | 1.042M |
| Aug 18, 2026 | 35.35 | 36.65 | 35.08 | 36.10 | 609433.0 |
| Aug 17, 2026 | 34.71 | 35.61 | 34.71 | 35.32 | 556782.0 |
| Aug 14, 2026 | 34.00 | 36.18 | 33.54 | 35.14 | 862900.0 |
| Aug 13, 2026 | 36.50 | 36.93 | 33.79 | 34.04 | 738225.0 |
| Aug 12, 2026 | 34.03 | 36.64 | 33.00 | 36.46 | 1.273M |
| Aug 11, 2026 | 34.84 | 35.13 | 33.78 | 34.42 | 477250.0 |
| Aug 10, 2026 | 35.00 | 35.66 | 34.09 | 34.84 | 982001.0 |
| Aug 07, 2026 | 35.00 | 35.77 | 34.45 | 34.91 | 696389.0 |
| Aug 06, 2026 | 33.60 | 36.02 | 33.60 | 34.45 | 570609.0 |
| Aug 05, 2026 | 34.13 | 34.45 | 32.65 | 33.42 | 386925.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novartis AG | 138.33 |
| BioAge Labs, Inc. | 8.72 |
| AstraZeneca PLC | 159.56 |
| ANI Pharmaceuticals, Inc. | 70.57 |
| Corcept Therapeutics, Inc. | 115.65 |
Price Related Metrics
| Price to Book Value | 7.892 |
| Earnings Yield | -7.89% |
| Market Cap | 2.714B |